Results 221 to 230 of about 71,357 (285)

Rabies virus as vector for development of vaccine: pros and cons. [PDF]

Front Vet Sci
Li Y, Zhou H, Li Q, Duan X, Liu F.
europepmc   +1 more source

Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle-Targeting Lipid Nanoparticles in Mice. [PDF]

Vaccines (Basel)
Li Q, Bai H, Yu X, Liu Q, Hu R.
europepmc   +1 more source

Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library. [PDF]

Viruses
Harisha KR, Kailaje V, Kondreddi RR, Gudla CS, Singh S, Ramakrishnaiah S, Isloor S, Narayanan S, Shandil RK, Rudramurthy GR.   +9 more
europepmc   +1 more source

Changes in the dynamic characteristics of G-protein can alter the immune-protection efficacy of rabies virus vaccine. [PDF]

J Virol
Chen C-x, Wang X, Su W, Tian Y, Gao Y, Liu D-l, Xiang H, Liu B-c, Shi J-l, Zhang Y, Shen D, He W-z, Yang L, Hong C, Wu F, Shi L-t, Cun Y-n, Zhou J.   +17 more
europepmc   +1 more source

Protocol for constructing and characterizing recombinant vectored vaccines for rabies virus. [PDF]

STAR Protoc
Khalifa ME, Munir M.
europepmc   +1 more source

A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice. [PDF]

Emerg Microbes Infect
Liu J, Sun J, Ding X, Liu W, Wang Y, Wang Z, Peng H, Zhang Y, Su W, Jiang C.   +9 more
europepmc   +1 more source

[The rabies virus].

Salud publica de Mexico, 1975
openaire   +1 more source